financing
Be Biopharma Raises $92M in Series C Financing to Advance Engineered B-Cell Therapies
The firm will use the proceeds to advance BE-101 for hemophilia B through clinical proof-of-concept testing and BE-102 for hypophosphatasia into the clinic.
First Ascent Biomedical Nabs $6M Investment to Advance Functional Precision Medicine Platform
The firm will use the funds to establish a commercial lab and continue advancing its AI- and sequencing-based platform for personalizing cancer treatment.
Tune Therapeutics Raises $175M in Series B Financing to Fund Hepatitis B Epigenetic Silencing Drug
Its lead candidate Tune-401, which aims to repress viral DNA that contributes to infection, has entered into clinical trials in New Zealand and Hong Kong.
Coave Therapeutics Raises $33M in Series A Financing
The French firm will use the proceeds to advance its ALIGATER platform for delivering genetic payloads and move its preclinical assets toward the clinic.
XyloCor Raises $67.5M in Series B Financing
The company will use the proceeds to test its gene therapy XC001 in two Phase II studies involving patients with cardiovascular disease.